Table 2.
Safety assessments
| Parameters | Results
|
|
|---|---|---|
| Group A | Group B | |
| Weight (kg) | ||
| Pretreatment | 72.27 (±12.29) | 74.05 (±12.27) |
| Visit two | 72.35 (±12.28 | 73.87 (±12.29) |
| Visit three | 72.42 (±12.31) | 74.04 (±12.39) |
| BMI | ||
| Pretreatment | 25.80 (±3.03) | 25.99 (±3.05) |
| Visit two | 25.80 (±3.013) | 25.96 (±3.099) |
| Visit three | 25.82 (±3.009) | 26.02 (±3.121) |
| Systolic blood pressure (mmHg) | ||
| Pretreatment | 123.7 (±8.541) | 123.7 (±7.285) |
| Visit two | 122.4 (±7.376) | 122.7 (±8.124) |
| Visit three | 122.4 (±7.813) | 123.0 (±7.644) |
| Diastolic blood presssure (mmHg) | ||
| Pretreatment | 80.29 (±7.42) | 80.14 (±8.269) |
| Visit two | 79.67 (±7.755) | 79.43 (±8.655) |
| Visit three | 80.04 (±7.576) | 79.38 (±8.672) |
| Pulse (bpm) | ||
| Pretreatment | 68.54 (±4.644) | 68.92 (±4.503) |
| Visit two | 68.17 (±5.165) | 68.47 (±5.647) |
| Visit three | 68.30 (±4.789) | 68.57 (±4.648) |
Notes: Data are n, or mean (±standard deviation). Group A: subjects treated with uridine, cytidine, and vitamin B12. Group B: subjects treated with vitamin B12 alone.
Abbreviations: BMI, body mass index; bpm, beats per minute.